BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update
May 02, 2024 07:30 ET
|
BridgeBio Pharma, Inc.
- Presented cardiac magnetic resonance (CMR) imaging evidence consistent with clinical improvement observed in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) in the ATTRibute-CM Phase 3...
Biogen Reports Progress on Corporate Responsibility Priorities
May 02, 2024 07:30 ET
|
Biogen Inc.
Efforts focused on four areas: access and health equity, workforce and DE&I, community impact and the environment CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB)...
The 2024 Xos SV Stepvan Now Available for Incentives on the HVIP Vehicle Catalog
May 02, 2024 07:30 ET
|
Xos, Inc.
Xos has received official approval from the California Air Resources Board (CARB) for the 2024 Xos SV Battery Electric Stepvan for HVIP.
Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024
May 02, 2024 07:30 ET
|
Anavex Life Sciences Corp.
NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics...
MGP Ingredients Declares $0.12 Quarterly Dividend
May 02, 2024 07:25 ET
|
MGP Ingredients
ATCHISON, Kan., May 02, 2024 (GLOBE NEWSWIRE) -- MGP Ingredients, Inc. (Nasdaq: MGPI), a leading provider of branded and distilled spirits as well as food ingredient solutions, today announced that...
HUB Cyber Security Awarded Key Contract by the Israeli Airports Authority
May 02, 2024 07:25 ET
|
HUB Cyber Security Ltd.
TEL AVIV, Israel, May 02, 2024 (GLOBE NEWSWIRE) -- via IBN – HUB Cyber Security Ltd. (Nasdaq: HUBC), a developer of confidential computing cybersecurity solutions and advanced data services ("HUB"...
Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024
May 02, 2024 07:25 ET
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., May 02, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive...
Ocugen Announces CSO to Present on Modifier Gene Therapy at Retina World Congress
May 02, 2024 07:15 ET
|
Ocugen
MALVERN, Pa., May 02, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
Alvotech Announces Participation at BofA Securities Healthcare Conference 2024
May 02, 2024 07:15 ET
|
Alvotech
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that members of management would be...
Vivid Seats Releases 2024 Environmental, Social and Governance Update
May 02, 2024 07:15 ET
|
Vivid Seats LLC
CHICAGO, May 02, 2024 (GLOBE NEWSWIRE) -- Vivid Seats Inc. (NASDAQ: SEAT), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers...